SCOTUS: Generics Not Liable for Injuries; Public Citizen Calls for Label Law Overhaul

Generic drugmakers cannot be sued in state courts for adverse events from an innovative drug’s design, the Supreme Court ruled Monday, cementing the idea that federal laws preempt states from taking a role in regulating drug safety and efficacy.
Drug Industry Daily